176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
32.37%
Revenue growth above 1.5x MRVL's 5.85%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
30.96%
Gross profit growth above 1.5x MRVL's 6.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.75%
EBIT growth above 1.5x MRVL's 7.21%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
37.75%
Operating income growth above 1.5x MRVL's 7.21%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
37.74%
Net income growth above 1.5x MRVL's 9.50%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
No Data
No Data available this quarter, please select a different quarter.
33.33%
Diluted EPS growth above 1.5x MRVL's 10.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
27.59%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
6.33%
Slight or no buyback while MRVL is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-49.52%
Negative OCF growth while MRVL is at 38.66%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-32.08%
Negative FCF growth while MRVL is at 93.90%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.15%
AR growth well above MRVL's 26.90%. Michael Burry fears inflated revenue or higher default risk in the near future.
221.37%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
28.36%
Asset growth above 1.5x MRVL's 2.81%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.76%
We have a declining book value while MRVL shows 1.08%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-63.33%
We’re deleveraging while MRVL stands at 5.86%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
24.19%
R&D growth drastically higher vs. MRVL's 2.23%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
33.33%
SG&A growth well above MRVL's 3.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.